Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q3 2023 Earnings

3AugConfirmed

Q4 2022

Q1 2023

Q2 2023

Q3 2023

-53.34

-43.91

-34.48

-25.04

Details

Expected EPS

-25.9824

Actual EPS

-38.280736

Surprise EPS

-12.3

Surprise Percent

+47.33%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -38.280736 per share for Q3 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.